RAINER M. BLAIR TO SUCCEED THOMAS P. JOYCE, JR. AS PRESIDENT AND CEO IN SEPTEMBER 2020 WASHINGTON, May 6, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) today announced that Executive Vice President, Rainer M. Blair, will succeed Thomas P. Joyce Jr. as President and Chief Executive Officer and as a member... Read more
WASHINGTON, May 6, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the quarter ended April 3, 2020. All results in this release reflect only continuing operations unless otherwise noted. For the first quarter 2020, net earnings were $595.1 million, or $0.81 per diluted common share. Non-GAAP adjusted diluted net earnings... Read more
Highest level of AOAC approval includes testing for foods such as romaine lettuce, raw salmon, dairy products and herbs and spices WALTHAM, Mass. – May 6, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced its Solus One™ Salmonella assay and methods have been granted First Action Official... Read more
Thermo Fisher Scientific to Present at BofA Securities 2020 Health Care Conference WALTHAM, Mass., May 6, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will participate in a virtual fireside chat at the BofA Securities 2020 Health Care Conference on... Read more
New Ion AmpliSeq SARS-CoV-2 Research Panel, now optimized for the Ion Torrent Genexus System*, assists with contact tracing to identify coronavirus hot spots CARLSBAD, Calif., May 6, 2020 /PRNewswire/ — As countries begin to ease restrictions and allow some businesses to reopen, contact tracing and epidemiological studies will be critical to understand resurgence of potential COVID-19... Read more
Revenue of $652.4 million; 1% reported growth; (1)% organic growth GAAP EPS from continuing operations of $0.30; Adjusted EPS of $0.67 Withdrawing previously disseminated FY20 guidance due to COVID-related uncertainties WALTHAM, Mass.–(BUSINESS WIRE)–May 5, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–May 5, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company) Anti-SARS-CoV-2 ELISA (IgG) serology test. Clinical laboratories certified to perform high complexity tests under Clinical... Read more
CERM of University of Florence, Italy Accepts Bruker 1.2 GHz NMR System BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the successful installation and customer acceptance of the world’s first Avance™ NEO1.2 GHz NMR system at the CERM (www.cerm.unifi.it) of the University of Florence. CERM is an Italian center of the European research infrastructure... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–May 1, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the annual BofA Securities Virtual Healthcare Conference 2020 on Thursday, May 14, 2020 at 8:20 a.m. ET. Prahlad Singh, president and chief executive officer for PerkinElmer, will provide... Read more
New MaxSignalTM HTS Nitrofurans and Chloramphenicol ELISA Kits combined with automation platform brings streamlined sample prep, faster testing and < 0.1ppb result sensitivity WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the introductionof its MaxSignalTM HTS Nitrofurans and Chloramphenicol ELISA Kits, which will help food safety, quality and aquaculture... Read more